Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS). Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle. The journal has seven main interest areas: Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs. Mechanisms of drug-disease and drug disease interactions and the role of different stress statesRheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugsGastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agentsNeuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and painNovel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g. NSAIDsMuscle-immune interactions during inflammation: mechanisms of inflammation and anti-inflammatory actions of therapeutic agents on skeletal muscle under conditions of aging or injury.Safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics

炎癥藥理學是國際基礎與臨床藥理學聯合會(IUPHAR)和匈牙利實驗與臨床藥理學學會(HECPS)胃腸部的官方出版物。炎癥藥理學發表關于炎癥及其藥理學控制的所有方面的論文，強調比較(a)不同的炎癥狀態，(b)用于炎癥條件治療的藥物的作用、治療效果和安全性。炎癥條件類型的比較方面包括胃腸道疾病(如潰瘍性結腸炎、克羅恩病)、寄生蟲病、藥物和環境制劑作用的毒理學表現、關節炎條件以及損傷或老化對骨骼肌的炎癥影響。該雜志有七個主要的興趣領域:藥物-疾病的相互作用-條件藥理學-也就是說，條件(疾病或壓力狀態)影響治療反應和抗炎藥物的副作用。藥物-疾病的機制和藥物-疾病的相互作用以及不同應激狀態的作用風濕病學-特別強調測量新制劑的臨床反應效果的方法，抗風濕藥物的副作用胃腸病學-特別強調動物和人類的模型，粘膜炎癥和潰瘍的機制和新的和建立的抗潰瘍，消炎劑，或抗寄生蟲劑的效果神經炎癥與疼痛模型系統，新型鎮痛藥的藥理學和神經炎癥與疼痛的機制新型藥物、天然產品和營養保健品——以及它們對炎癥過程的影響，特別是與傳統藥物(如非甾體抗炎藥)相比，有新模式作用的跡象的地方炎癥過程中的肌肉免疫相互作用:炎癥機制和治療藥物在衰老或損傷條件下對骨骼肌的抗炎作用。非處方藥(OTC)和非處方藥、鎮痛藥的安全性和有效性